Top Companies in the Buoyancy Activated Cell Sorting (BACS) Market & Their Offerings
| Companies | Headquarters | Offerings |
| Terumo Corporation | Tokyo, Japan | Provides advanced medical and blood management technologies, supporting cell processing and separation workflows used in research and clinical applications. |
| STEMCELL Technologies Inc. | Vancouver, Canada | Specializes in cell isolation kits, culture media, and reagents, widely used in gentle cell separation and stem cell research applications. |
| Bio-Rad Laboratories, Inc. | California, USA | Offers cell analysis instruments, reagents, and separation technologies supporting research and diagnostic workflows. |
| Merck KGaA | Darmstadt, Germany | Provides a broad portfolio of life science tools, including cell culture systems, reagents, and filtration technologies relevant to cell sorting processes. |
| GE HealthCare | Illinois, USA | Delivers bioprocessing systems, cell therapy manufacturing solutions, and analytical tools supporting advanced cell separation and processing. |
| Miltenyi Biotec | Bergisch Gladbach, Germany | Known for cell separation technologies, including magnetic-based sorting systems, reagents, and automated platforms used in research and clinical cell processing. |
What are the Recent Developments in the Buoyancy Activated Cell Sorting (BACS) Market?
- In February 2026, New research demonstrated buoyancy-based sorting applications in synthetic cell systems, highlighting the expanding use of BACS beyond traditional cell isolation into advanced bioengineering fields.
- In December 2025, Akadeum Life Sciences launched the CDMO Alliance Program to accelerate the commercialization of microbubble-based cell sorting, improving scalability and reducing cell therapy manufacturing costs.
Supply Chain Analysis
R&D
- Buoyancy Activated Cell Sorting (BACS) is a gentle and advanced cell separation method that uses antibody-coated microbubbles to attach to specific cells and lift them to the surface for easy isolation. Current R&D is focused on developing fast, application-specific kits (around 30 minutes) for uses such as immunology studies, dead cell removal, and circulating tumor cell detection.
- Key players: Akadeum Life Sciences, Thermo Fisher Scientific, Merck KGaA, and Bio-Rad Laboratories.
Clinical Trials
- Buoyancy Activated Cell Sorting (BACS) is a novel, gentle cell separation approach that uses functionalized microbubbles to lift specific cells, such as T-cells and stem cells, for easy collection. It is mainly used in pre-clinical research today, but is showing strong potential in CAR-T manufacturing and is gradually moving toward clinical diagnostics and therapeutic use
- Key players: Akadeum Life Sciences, STEMCELL Technologies, Miltenyi Biotec, and BD Biosciences.
Regulatory Approvals
- Regulatory focus for Buoyancy Activated Cell Sorting (BACS) is centered on confirming safety, consistent performance, and reliable results as the technology advances toward clinical use. As adoption grows, companies are aligning with strict validation and quality standards to support approvals.
- Key players: Akadeum Life Sciences, Beckman Coulter, Sartorius AG, and Agilent Technologies.
Market Growth
The global buoyancy activated cell sorting (BACS) market size was estimated at USD 185 million in 2025 and is predicted to increase from USD 208.68 million in 2026 to approximately USD 616.97 million by 2035, expanding at a CAGR of 12.8% from 2026 to 2035. The market is growing due to increasing demand for precise, label-free cell separation in biopharmaceutical research and advanced diagnostics. Growth is further supported by innovations in microfluidics and automation, though high costs and technical complexity may limit widespread adoption.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking